SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

The conversation is dominated by frustration over stagnant price action and reliance on clinical updates from the REDUCE-IT study while awaiting a Supreme Court ruling on the Hikma litigation. Traders are debating the company's long-term potential, including speculation regarding a new formulation and potential M&A activity facilitated by Barclays.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is currently receiving attention due to its proximity to 52-week lows, sparking intense debate among traders over whether the stock presents a deep-value buying opportunity or is fundamentally declining due to consumer spending concerns and high pricing. Many community members are debating its valuation as a defensive blue chip versus its performance compared to competitors, while technical traders are closely monitoring key support levels for a potential reversal.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

The community is debating the project's long-term utility, with many traders accumulating positions while citing ICP's infrastructure capabilities and AI-native ecosystem as reasons for their bullish outlook. Conversely, a vocal group of traders remains bearish, citing consistent price underperformance, poor tokenomics, and lack of immediate adoption compared to broader market gains.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is receiving attention as traders debate its long-term potential, with bulls highlighting the recent v5.0 mainnet upgrade and the project's focus on quantum-resistant cryptography. While supporters view current prices as an accumulation opportunity before an expected altcoin market recovery, critics remain skeptical due to the coin's long-term price decline and ongoing token dilution concerns.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is trending amid speculative retail interest regarding its potential as a short-squeeze candidate, driven by its high short interest and relatively small float. Traders are debating the viability of a squeeze compared to other consumer-facing stocks, with some highlighting the company's debt restructuring and turnaround efforts as catalysts for potential upside.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending as traders speculate on upcoming regulatory developments and institutional adoption, with the community focused on the potential impact of the Clarity Act and recent increases in institutional inflows. While many express optimism about long-term infrastructure growth, sentiment remains divided with some traders raising concerns over market volatility and dilution.

Cheesecake Factory, Inc. engages in the operation of restaurant chains. It operates through the following segments: The Cheesecake Factory Restaurants, North Italia, Other FRC, and Other. The Cheesecake Factory Restaurants segment offers appetizers, pizza, seafood, steaks, chicken, burgers, small plates, pastas, salads, sandwiches and omelettes, and a selection of gluten-free items. The North Italia segment specializes in Italian cuisine. The Other FRC segment includes brands acquired from Fox Restaurant Concepts. The Other segment consists of the Flower Child brand, along with other businesses. The company was founded by David M. Overton, Oscar Overton, and Evelyn Overton in 1972 and is headquartered in Calabasas Hills, CA.

Cheesecake Factory Inc. (The)

Cheesecake Factory Inc.

Cheesecake Factory is experiencing significant volatility as investors debate its valuation and growth prospects, with many traders expressing skepticism over the stock's year-to-date rally and elevated RSI levels. While some investors highlight the company's strong brand and expansion of concepts like North Italia and Flower Child as long-term catalysts, others argue the price is overextended, pointing to recent insider selling and concerns about the broader consumer spending environment.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending following its second-quarter earnings report, which revealed that the conglomerate has transitioned from a multi-quarter net seller of equities to a net buyer, including a significant new stake in Alphabet. While some investors see this as a sign of renewed capital deployment and long-term confidence, others express frustration with the stock's multi-year performance lag relative to broader market benchmarks and debate the company's strategic direction under CEO Greg Abel.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is seeing sustained bullish sentiment driven by a potential short squeeze, with traders citing high short interest and limited float as core factors. Community discussion focuses on a "controlled grind" strategy, where investors anticipate that institutional buying and ongoing share repurchases will pressure shorts, potentially triggering a significant move as the stock tests key technical levels.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor is trending as traders speculate on its potential for decentralized AI infrastructure, with recent discussions highlighting developer updates, subnets, and the broader integration of AI into blockchain systems. While some sentiment remains cautious due to price volatility, many participants are focusing on long-term accumulation and the network's technological evolution as a potential alternative to centralized AI models.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SCYX 
Maxim update Part 2
On 8/10, Scynexis reported 2Q results with opex of $8.0M and a non-cash gain on derivative liabilities of $14.1M, for a net gain of $7.4M. The company ended the period with $71.1M in cash on the balance sheet which should provide sufficient runway into 2029.
The P1 for its oral direct AMPK activator SCY-770, started in late June and is due to report data by the end of 3Q26. The data should inform the design of a P2 study in autosomal dominant polycystic kidney disease (ADPKD) patients, which is expected to start in 4Q26, representing a key event for Scynexis in its transformation into a rare-disease company.

StockTwits For Android 

Scynexis Inc

 
Maxim update Part 2
On 8/10, Scynexis reported 2Q results with opex of $8.0M and a non-cash gain on derivative liabilities of $14.1M, for a net gain of $7.4M. The company ended the period with $71.1M in cash on the balance sheet which should provide sufficient runway into 2029.
The P1 for its oral direct AMPK activator SCY-770, started in late June and is due to report data by the end of 3Q26. The data should inform the design of a P2 study in autosomal dominant polycystic kidney disease (ADPKD) patients, which is expected to start in 4Q26, representing a key event for Scynexis in its transformation into a rare-disease company.